MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
57.66
+0.83
+1.46%
Closed 15:59 02/11 EST
OPEN
57.32
PREV CLOSE
56.83
HIGH
57.99
LOW
56.94
VOLUME
202.97K
TURNOVER
11.69M
52 WEEK HIGH
58.33
52 WEEK LOW
34.85
MARKET CAP
--
P/E (TTM)
22.82
1D
5D
1M
3M
1Y
5Y
1D
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Seeking Alpha · 19h ago
Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know
NASDAQ · 1d ago
International ETFs to Watch as Foreign Stock Markets Beat the US
NASDAQ · 1d ago
Roche price target raised to $67 from $60 at TD Cowen
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Roche Holding (OtherRHHBY) and Intuitive Surgical (ISRG)
TipRanks · 2d ago
Roche Says Experimental Drug Helped Slow Disability In Progressive Multiple Sclerosis Study
Benzinga · 2d ago
Weekly Report: what happened at RHHBY last week (0202-0206)?
Weekly Report · 3d ago
VIG vs. VYM vs. VYMI: Which Is Vanguard’s Best Dividend ETF for Reliable Passive Income?
TipRanks · 3d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.